Innovative skincare technology secures new license agreemen

16 August 2023

Innovative skincare technology secures new license agreement

Blis Technologies (NZX: BLT) is pleased to announce the signing of an agreement with a significant Australasian cosmetic skincare company to licence our cosmetic facial live probiotic serum containing BLIS Q24®. The agreement allows for exclusive marketing of the Blis developed serum formulation under the partner’s brand domestically and in export markets where the partner has a significant presence in both retail and online sales.

Further details of the agreement and relationship cannot be disclosed at this time to maintain confidentiality.
Blis CEO Brian Watson said “We are excited to have finalised this first Business to Business relationship for our skincare technology. Our strategy has been to secure partnerships with established regional brands who have the capability to launch this breakthrough product in selected markets. This relationship further validates the value of our innovation and the exciting future for our skincare focus.”

What this agreement means for Blis:
• Recognition of Blis’ world class innovation in cosmetic skincare
• The first B2B initiative for skincare, in line with our revised strategy of targeting partnerships with established cosmetic skincare companies
• New ingredient revenue and technology licensing royalties expected to have a small positive impact on earnings in FY24 and solid growth in the following years

Ends

For further information, please contact:

Brian Watson
CEO
+64 27 705 9133


About Blis Technologies Ltd

Delivering proven health benefits through evidence-based, advanced probiotics
Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz.

About the BLIS Q24™ Live Probiotic Serum
Enriched with a live probiotic in a shelf-stable topical format, the BLIS Q24™ Live Probiotic Serum is proven to address various skin concerns and help to maintain a healthier, more radiant complexion.
BLIS Q24™ is a patented strain of Micrococcus Luteus, a commensal and beneficial species of bacteria naturally found in the skin. The strain was isolated in 2004 by Professor Emeritus John Tagg, who recognised its unparalleled ability to inhibit the growth of key skin pathogens that can cause damage to human skin.

Website: www.blis.co.nz

Instagram: @blisprobiotics #blisk12 #blism18 #blisq24
Facebook: @BLISProbiotics

---

Announcement PDF